Table 1

Baseline Characteristics of Trial Participants (Per-Protocol Analysis)

CharacteristicOverall (N = 97)aIntervention Group (n = 46)aControl Group (n = 51)aP Value
Age, y, mean (SD)59.5 (11.2)59.8 (10.8)59.3 (11.7).811
Sex, No. (%).022
 Male39 (40.2)24 (52.2)15 (29.4)
 Female58 (59.8)22 (47.8)36 (70.6)
Ethnicity, No. (%).440
 Malay88 (90.7)43 (93.5)45 (88.2)
 Indian6 (6.2)2 (4.3)4 (7.8)
 Chinese1 (1.0)1 (2.2)0 (0)
 Other2 (2.1)0 (0)2 (3.9)
Education level, No. (%).282
 No formal education4 (4.1)1 (2.2)3 (5.9)
 Elementary29 (29.9)13 (28.3)16 (31.4)
 High school43 (44.3)20 (43.5)23 (45.1)
 College/university21 (21.6)12 (26.1)9 (17.6)
Days fasted during Ramadan, median (IQR)30 (26-30)30 (27-30)30 (26-30).896
Duration of diabetes, y, median (IQR)10 (5.0-20.0)10 (5.0-15.0)11 (4.5-21.5).529
Number of comorbidities, mean (SD)3.75 (1.24)3.72 (1.24)3.78 (1.25).793
Diabetes regimen, No. (%).084
 Insulin only2 (2.1)2 (4.3)0 (0)
 Oral therapy only59 (60.8)31 (67.4)28 (54.9)
Insulin and oral therapy36 (37.1)13 (28.3)23 (45.1)
BMI, kg/m2, mean (SD)30.3 (5.5)29.7 (5.6)30.8 (5.4).352
HbA1c, mean (SD).932
 %7.8 (0.9)7.8 (0.9)7.8 (0.9)
 mmol/mol62 (9.9)62 (9.9)62 (9.9)
Fasting blood glucose, mg/dL, mean (SD)120.8 (28.9)123.7 (27.1)118.6 (32.5).283
Postprandial glucose, mg/dL, mean (SD)196.4 (55.9)191.0 (41.5)201.8 (68.5).867
Creatinine clearance, mL/min, mean (SD)60.3 (29.6)58.8 (30.1)61.7 (29.4).635
  • BMI = body mass index; HbA1c = glycated hemoglobin; IQR = interquartile range.

  • a Data are presented as number (%) for categoric variables, mean (SD) for normally distributed continuous variables, and median (IQR) for nonnormally distributed continuous variables.